Literature DB >> 29619771

A Study of Triplet-Primed PCR for Identification of CAG Repeat Expansion in the HTT Gene in a Cohort of 503 Indian Cases with Huntington's Disease Symptoms.

Pratiksha Chheda1, Milind Chanekar2, Yogita Salunkhe2, Tavisha Dama2, Anurita Pais3, Shailesh Pande3, Rajesh Bendre2, Nilesh Shah2.   

Abstract

BACKGROUND: Huntington's disease (HD) is an autosomal-dominant neurodegenerative disorder with an average age at onset of 40 years. It is a polyglutamine (polyQ) disorder that is caused by an increase in the number of CAG repeats in the huntingtin (HTT) gene. Genetic tests that accurately determine the number of CAG repeats are performed for confirmation of diagnosis, predictive testing of persons at genetic risk for inheriting HD, and prenatal testing. The aim of our study was to evaluate efficacy of triplet-primed polymerase chain reaction (TP-PCR) for routine diagnosis of HD in suspected cases from India.
METHODS: We evaluated a combination of CAG flanking PCR and triplet-primed PCR for estimation of CAG repeats in 503 cases with clinical suspicion of HD.
RESULTS: There were 250 cases (49.7%) that showed the presence of expanded alleles, with 241 (47.9%) being fully penetrant alleles and nine (1.8%) in the reduced penetrance category. There were seven juvenile cases with an age of onset of < 20 years, with the longest allele comprising 106 CAG repeats found in an 8-year-old male patient. The results demonstrated an inverse (R = - 0.67) relationship between CAG length and age at clinical onset.
CONCLUSION: Our study on pan-Indian cases is one of the largest studies reported so far in India and focuses on the most accurate and comprehensive molecular diagnostic evaluation of HD.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29619771     DOI: 10.1007/s40291-018-0327-y

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN: 1177-1062            Impact factor:   4.074


  24 in total

1.  Large normal and reduced penetrance alleles in Huntington disease: instability in families and frequency at the laboratory, at the clinic and in the population.

Authors:  J Sequeiros; E M Ramos; J Cerqueira; M C Costa; A Sousa; J Pinto-Basto; I Alonso
Journal:  Clin Genet       Date:  2010-10       Impact factor: 4.438

2.  Huntington disease: DNA analysis in Brazilian population.

Authors:  S Raskin; N Allan; H A Teive; F Cardoso; M S Haddad; G Levi; R Boy; J Lerena Junior; V S Sotomaior; M Janzen-Dück; L B Jardim; F R Fellander; L A Andrade
Journal:  Arq Neuropsiquiatr       Date:  2000-12       Impact factor: 1.420

Review 3.  Lessons from animal models of Huntington's disease.

Authors:  David C Rubinsztein
Journal:  Trends Genet       Date:  2002-04       Impact factor: 11.639

4.  Technical standards and guidelines for Huntington disease testing.

Authors:  Nicholas T Potter; Elaine B Spector; Thomas W Prior
Journal:  Genet Med       Date:  2004 Jan-Feb       Impact factor: 8.822

5.  Enhanced Detection and Sizing of the HTT CAG Repeat Expansion in Huntington Disease Using an Improved Triplet-Primed PCR Assay.

Authors:  Mingjue Zhao; Caroline G Lee; Hai-Yang Law; Samuel S Chong
Journal:  Neurodegener Dis       Date:  2016-05-21       Impact factor: 2.977

6.  Single-step scalable-throughput molecular screening for Huntington disease.

Authors:  Clara R L Teo; Wen Wang; Hai Yang Law; Caroline G Lee; Samuel S Chong
Journal:  Clin Chem       Date:  2008-04-10       Impact factor: 8.327

7.  Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.

Authors:  Nancy S Wexler; Judith Lorimer; Julie Porter; Fidela Gomez; Carol Moskowitz; Edith Shackell; Karen Marder; Graciela Penchaszadeh; Simone A Roberts; Javier Gayán; Denise Brocklebank; Stacey S Cherny; Lon R Cardon; Jacqueline Gray; Stephen R Dlouhy; Sandra Wiktorski; Marion E Hodes; P Michael Conneally; Jack B Penney; James Gusella; Jang-Ho Cha; Michael Irizarry; Diana Rosas; Steven Hersch; Zane Hollingsworth; Marcy MacDonald; Anne B Young; J Michael Andresen; David E Housman; Margot Mieja De Young; Ernesto Bonilla; Theresa Stillings; Americo Negrette; S Robert Snodgrass; Maria Dolores Martinez-Jaurrieta; Maria A Ramos-Arroyo; Jacqueline Bickham; Juan Sanchez Ramos; Frederick Marshall; Ira Shoulson; Gustavo J Rey; Andrew Feigin; Norman Arnheim; Amarilis Acevedo-Cruz; Leticia Acosta; Jose Alvir; Kenneth Fischbeck; Leslie M Thompson; Angela Young; Leon Dure; Christopher J O'Brien; Jane Paulsen; Adam Brickman; Denise Krch; Shelley Peery; Penelope Hogarth; Donald S Higgins; Bernhard Landwehrmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

Review 8.  Huntington's disease and Huntington's disease-like syndromes: an overview.

Authors:  Felix Gövert; Susanne A Schneider
Journal:  Curr Opin Neurol       Date:  2013-08       Impact factor: 5.710

9.  American College of Medical Genetics and Genomics Standards and Guidelines for Clinical Genetics Laboratories, 2014 edition: technical standards and guidelines for Huntington disease.

Authors:  Lora Bean; Pinar Bayrak-Toydemir
Journal:  Genet Med       Date:  2014-10-30       Impact factor: 8.822

10.  Trinucleotide repeats and haplotypes at the huntingtin locus in an Indian sample overlaps with European haplogroup a.

Authors:  Nagaraj S Moily; Lakshmi Narayanan Kota; Ram Murthy Anjanappa; Sowmya Venugopal; Radhika Vaidyanathan; Pramod Pal; Meera Purushottam; Sanjeev Jain; Mahesh Kandasamy
Journal:  PLoS Curr       Date:  2014-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.